Intrinsic Value of S&P & Nasdaq Contact Us

Edgewise Therapeutics, Inc. EWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$38.67
+16.6%

Stock Statistics — EWTX

Edgewise Therapeutics, Inc. (EWTX) has a market capitalization of $3.56B and trades at $33.16. The 52-week range is 10.6-33.555.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -20.3, Earnings Per Share (EPS) of $-1.63.

The stock has a beta of 0.25, operates in the Healthcare sector.

Trading Data
Current Price$33.16
52-Week Range10.6-33.555
Volume1.05M
Avg Volume (30D)931.93K
Market Cap$3.56B
Beta (1Y)0.25
Company
IPO Date2021-03-26
Employees117
CEOKevin Koch
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS28036F1057
CUSIP28036F105
Income (Latest Year)
Gross Profit$-2.27M
EBITDA$-165.53M
Operating Income$-191.41M
Net Income$-167.8M
EPS$-1.63
EPS Diluted$-1.63
Shares Outstanding$102.93M
Balance Sheet (Latest Year)
Total Assets$552.6M
Current Assets$543.39M
Cash & ST Investments$530.11M
Total Liabilities$30.35M
Total Debt$3.99M
Net Debt$-57.16M
Total Equity$522.26M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-20.3
P/B Ratio6.81
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message